You don’t expect a routine checkup to change your life. But for too many Black men, that’s exactly how it happens, one conversation, one test result, and suddenly everything shifts. You have prostate cancer. For many Black men and their families, that moment carries...

This Managing Survivorship session was titled Treatment Options Update for Patients Newly Diagnosed or with Recurrent Prostate Cancer. The speakers included PHEN Director of Clinical Trials and Patient Education, Dr. Keith Crawford, and PHEN Senior Scientific Research...

If you’re a prostate cancer patient, you’ve likely heard how helpful fitness is for your health. However, did you know physical fitness can help you manage the side effects of treatment? How about the best type of exercise for prostate cancer survivors? Keep reading...

As part of the Jackson, MS Disparity Rally, Dr. Timothy Quinn, the Medical Director of Quinn Healthcare, explains the importance of early prostate cancer detection to save lives. Dr. Quinn advises men to visit PHENPath.com for information on the latest prostate cancer...

PHENPath.com - Empowering Patients Drawing on his experience as a prostate cancer survivor, PHEN President Thomas A. Farrington explains that newly diagnosed prostate cancer patients often lack knowledge about the right treatment pathways for their needs. To solve...

PHEN's Clinical Trials Rally's approach of educating Black prostate cancer patients about clinical trials, as well as strategic partnerships with pharmaceutical companies to amplify this message, is contributing to greater diversity among clinical trial participants....

The U.S. Food and Drug Administration (FDA) recently approved TALZENNA (talazoparib) in combination with XTANDI (enzalutamide) for the treatment of adult patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer...

  This information is provided for educational purposes only to support patients in understanding and discussing appropriate treatment options with their doctors. [button...

PHEN, The Prostate Health Education Network, Inc. is a leading patient education and advocacy organization with programs and initiatives nationwide. PHENPath.com was developed to help patients understand their treatment pathways and treatment options. We invite you to...

PHEN is a partner organization of the Amgen Clinical Pathways initiative, PHENPath.com helps empower prostate cancer patients through its first digital treatment pathway tool of its kind. We encourage you to read the article by clicking the button link below [button...

  PHENPath.com provides information for patients who want to better understand their initial Prostate cancer diagnosis. ...

Webinar: A Presentation and Patient Roundtable Discussion The following webinar was presented March 31, 2021. This webinar focused on real-life experiences and helped to demonstrate how to use PHENPath.com to navigate your prostate cancer journey.Understanding...